EMA Authorised: Inhixa (enoxaparin sodium) — Techdow Pharma Netherlands B.V.

View source ↗

Summary

The EMA authorised Inhixa (enoxaparin sodium) for the prevention and treatment of venous thromboembolism, with Techdow Pharma Netherlands B.V. as the marketing …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Venous Thromboembolism

Drugs mentioned

• Inhixa (enoxaparin sodium)

Snippet

Status: Authorised. Therapeutic area: Venous Thromboembolism. MAH: Techdow Pharma Netherlands B.V.. Decision date: 05/03/2026